Search results
Results from the WOW.Com Content Network
Martin Shkreli (/ ˈ ʃ k r ɛ l i /; born March 17, 1983) is an American investor and businessman.Shkreli is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare, the co-founder and former CEO of pharmaceutical firms Retrophin and Turing Pharmaceuticals, and the former CEO of start-up software company Gödel Systems, which he founded in August 2016.
Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term ...
Carlo Allegri/File Photo via Reuters“Pharma bro” Martin Shkreli is out of prison—and already back on Facebook.One of the first things the smirking fraudster did when he was released early ...
Martin Shkreli, the notorious so-called “Pharma bro” who garnered controversy when he significantly raised the price of AIDS medication, was released from prison on Wednesday. The Federal ...
Martin Shkreli, a former pharmaceutical investor convicted of securities fraud, has been released from prison after serving part of a seven-year sentence.
Martin Shkreli: 87850-053: Released May 18, 2022 after serving four years, two months [13] Nicknamed the "pharma bro." Convicted of securities fraud. Was originally at Fort Dix, until it was discovered he was still running his company via a contraband cellphone, which led to his transfer to Allenwood. Tal Prihar: 12911-509
Since his May 2022 release from prison, Shkreli has worked as a software developer and as a consultant for a law office. The case is Federal Trade Commission et al v. Shkreli, 2nd U.S. Circuit ...
A federal appeals court upheld the conviction and seven-year prison term of Martin Shkreli, the pharmaceutical executive known as "Pharma Bro," for defrauding investors in his hedge funds and ...